Beyond the APC era Alternative pathways to CRC. Jeremy R Jass McGill University
|
|
- Michael Bradley
- 5 years ago
- Views:
Transcription
1 Beyond the APC era Alternative pathways to CRC Jeremy R Jass McGill University
2 Outline Limitations of APC model KRAS and serrated polyps CRC and CpG island methylation Serrated pathway to CRC Fusion pathways
3 Adenoma-carcinoma sequence APC KRAS TP53 Normal Small adenoma Large adenoma Cancer Genetic instability
4 Familial adenomatous polyposis
5 Mutation in sporadic colorectal neoplasia Dys ACF TAD CRC APC 19% 33% 60% KRAS 63% 11% 35% TP53 0% 0% 50% B-CAT 0% 13% 0%
6 Interpretation of mutational spectrum in colorectal neoplasms Minute adenomas initiated by APC or KRAS Mutation of APC and KRAS can occur during progression to CRC Progression to CRC is more likely when both APC and KRAS are mutated Progression more likely if APC mutated first Initiation of TADs explained by multiple mechanisms, not all of which are known Few CRCs have mutation of APC, KRAS & TP53 (Smith et al, PNAS 2002;99:9433)
7 KRAS and serrated polyps
8 RAS-RAF-MEK-ERK-MAP-kinase pathway and inhibition of apoptosis KRAS*: Up-regulation of prosurvival Akt/PKB: inactivation of caspase-9 and Bad BRAF*: Inhibition of cytosolic caspase activation following release of mitochondrial cytochrome c *Mutation of either confers resistance to DNA damageinduced apoptosis
9 Inhibition of apoptosis Loss of anchorage Integrin Basal lamina Cell membrane FAK/PI-3K Ras Akt/PKB caspase-2 caspase-7 caspase-3 caspase-9 Raf X X Bad Cytochrome c release from mitochondria
10 KRAS, BRAF and DNA methylation Ras RASSF1 Nore1 Raf RasGAP PI3-K Tiam1 Mst1 Mst1 MEK Rsk AKT Rac ERK Bad Casp9 IKK FKH Pro-apoptosis Bcl-2 Anti-apoptosis NF-κB
11 Pleiotropism of KRAS Hyperplastic ACF 100% Dysplastic ACF 63% Hyperplastic polyp 40% Serrated adenoma 20% Adenoma 15 to 75% CRC 35%
12 Pathogenesis of serrated polyps Inhibition of exfoliation Inhibition of apoptosis (anoikis) Retention of surface epithelium Cell senescence Growth by crypt fission
13 Incomplete apoptosis in SP Denatured CK18 without exfoliation? caspase-2 caspase-7 IHC M30/cytodeath CK18
14 CRC and CpG Island Methylation (CIMP)
15 Molecular classification of CRC Diploid Aneuploid MSI MSS Meth+ Meth
16 Features of CIMP-Pos/ MSS or MSI-L CRC MSI-High-like: Proximal, Mucinous, Poor diff, Serrated, F>M, BRAF+ Non-MSI-H-like: Early onset, few TILs, aggressive, meth MGMT, KRAS (when not BRAF+)
17 Serrated carcinoma in 17-year-old female MGMT
18 Serrated pathway to colorectal cancer
19 Classification of epithelial polyps Neoplastic* Adenoma (TA,TV,VA) Mixed polyp Serrated adenoma Non-neoplastic Hyperplastic polyp Spectrum of serrated polyps *Characterized by cancer-associated genetic alteration
20 HP-GC HP-MV SSP SA
21 Mixed polyps Collision? (HP and AD) Sequence? (HP to AD) - Identical genetic changes (MSI) in both components - Adenomatous component usually serrated
22 SA HP N D2S123
23 Serrated pathways BRAF/KRAS & DNA Meth MLH1 MP MSI-H CRC N HP MGMT MP MSI-L/ MSS CRC
24 BRAF and KRAS mutation in colorectal polyps TA TV HP SSP MP SA n.62 n.23 n.46 n.32 n.13 n.15 BRAF 3 (5%) 2 (9%) 30 (65%) 26 (81%) 7 (54%) 5 (33%) KRAS 11 (18%) 11 (48%) 1 (2%) 1 (3%) 6 (46%) 4 (27%)
25 Patterns of immunohistochemical expression of DNA repair genes Sporadic loss in hyperplastic crypts Loss in expanded and dysplastic subclones (when mutation gives growth advantage)
26
27 MLH1
28 MGMT
29 MGMT
30 HNPCC-like families with variable MSI status (Young et al. 2005)
31 Hyperplastic polyposis
32 Serrated pathway syndrome (SPS) (11 families from Qld Registry) MSI-variable CRC Mean age of onset 60 years/ F>M Variable polyp background (HP, SA mixed polyp, AD, SSA) Hyperplastic polyposis in up to 10% Concordant DNA methylation in polyps and cancers Concordant mutation of BRAF in most polyps and cancers Unrecognized (confused with HNPCC and FAP, low/mod penetrance and variable phenotype)
33 MGMT and fusion pathways to CRC
34 O-6-Methylguanine DNA Methyltransferase (MGMT) Overloaded MMR MSI-L MGMT methylation methylg:t mismatches Futile cycles of DNA repair CIN Demethylation* Mutation KRAS/TP53 *Nasr et al, Mutations of TP53 induce loss of DNA methylation Oncogene 2003;22:1668
35 Loss of MGMT in advanced serrated polyps (MP, SA, SSA) versus adenomas (Higuchi et al, 2005) Frequency R colon Size Type SP 24% Yes Yes NA AD 13% No No No
36 CRC arising in adenoma Re-expression of MGMT
37 Concept of fusion pathways 1. Adenoma APC TP53 2. Serrated polyp BRAF or KRAS DNA methylation
38 Concept of fusion pathways 1. Adenoma APC TP53 2. Serrated polyp BRAF or KRAS DNA methylation Fusion pathway A MGMT & KRAS Serration/villous
39 Concept of fusion pathways 1. Adenoma APC TP53 2. Serrated polyp BRAF or KRAS DNA methylation Fusion pathway A Fusion pathway B MGMT & KRAS Serration/villous APC/Wnt MGMT & TP53 MLH1 intact Dysplasia
40 MGMT MGMT 1. Adenoma with serration 2. Serrated polyp with dysplasia
41 Conclusion Not all adenomas or CRCs are initiated by APC mutation Most adenomas are dead-end lesions CRCs with DNA methylation are initiated by BRAF or KRAS (serrated pathway) and represent c. 25% of CRC
Serrated Polyps and a Classification of Colorectal Cancer
Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram
More informationGeneral Session 7: Controversies in Screening and Surveillance in Colorectal Cancer
General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer Complexities of Pathological Assessment: Serrated Polyps/Adenomas Carolyn Compton, MD, PhD Professor of Life Sciences,
More informationDevelopment of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationColon Cancer and Hereditary Cancer Syndromes
Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models
More informationSessile Serrated Polyps
Årsmøtet i Den norske Patologforening 2014 Sessile Serrated Polyps Tor J. Eide Oslo Universitetssykehus The term serrated include a group of lesions with a sawtoothlike appearance of the crypts and the
More informationArzu Ensari, MD, PhD Department of Pathology Ankara University Medical School
Precursors of Colorectal Carcinoma Arzu Ensari, MD, PhD Department of Pathology Ankara University Medical School Hyperplastic polyp Adenomatous polyp Colorectal carcinoma IBD-associated (1-2%) Sporadic
More informationDisclosure slide I Member of advisory board for AMGEN, ROCHE, BOEHRINGER I Speaker honoraria from FALK Pharma, Pfizer, Lilly and ROCHE I Third party f
Early (and not so early) colorectal cancer: The pathologist s point of view Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Disclosure slide I Member of advisory board for
More informationEarly (and not so early) colorectal cancer: The pathologist s point of view
Early (and not so early) colorectal cancer: The pathologist s point of view Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Disclosure slide I Member of advisory board for
More informationSerrated Lesions in the Bowel Cancer Screening Programme
Serrated Lesions in the Bowel Cancer Screening Programme Mark Arends Cambridge & Edinburgh Serrated Lesions of Large Bowel 1. Hyperplastic polyp 2. Serrated adenoma 3. Mixed polyp 4. Sessile serrated lesion
More informationGeneral Surgery Grand Grounds
General Surgery Grand Grounds University of Colorado Health Sciences Center Case Presentation December 24, 2009 Adam Lackey, PGY-5 J.L. - 2111609 27 YO female with chief complaint of abdominal pain. PMHx:
More informationA WHO update on Serrated Polyps
A WHO update on Serrated Polyps Arzu Ensari, MD, PhD Department of Pathology Ankara University Medical School Am J Gastroenterol. 2010 Nov 2. [Epub ahead of The Clinical Significance of Serrated Polyps.
More informationSerrated Colorectal Polyps New Challenges to Old Dogma. Kenneth Batts, M.D. Abbott Northwestern Hospital Minneapolis, MN
Serrated Colorectal Polyps New Challenges to Old Dogma Kenneth Batts, M.D. Abbott Northwestern Hospital Minneapolis, MN A Sneak Preview.... This was in the good old days: Adenomas HPPs Mixed Polyps A Sneak
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationHyperplastische Polyps Innocent bystanders?
Hyperplastische Polyps Innocent bystanders?? K. Geboes P th l i h O tl dk d Pathologische Ontleedkunde, KULeuven Content Historical Classification Relation Hyperplastic polyps carcinoma The concept cept
More informationColonic Polyp. Najmeh Aletaha. MD
Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationGenetic testing all you need to know
Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes
More informationB Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696
Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591
More informationSynchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum
Tsumura T, et al 1 Synchronous and Subsequent Lesions of Serrated Adenomas and Tubular Adenomas of the Colorectum T. Tsumura a T. Hiyama d S. Tanaka b M. Yoshihara d K. Arihiro c K. Chayama a Departments
More informationTumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer
TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial
More informationHisto-prognostic factors what histopathology has to offer for clinical decision making
Histo-prognostic factors what histopathology has to offer for clinical decision making Daniela E. Aust Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics
More informationD uring the past few years, it has become
682 REVIEW My approach to serrated polyps of the colorectum T Higuchi, J R Jass... Hyperplastic polyps of the colorectum are heterogeneous lesions, a subset of which is now regarded as the precursor of
More informationCarcinogenesis in IBD
Oxford Inflammatory Bowel Disease MasterClass Carcinogenesis in IBD Dr Simon Leedham, Oxford, UK Oxford Inflammatory Bowel Disease MasterClass Carcinogenesis in Inflammatory Bowel Disease Dr Simon Leedham
More informationSerrated Colorectal Polyps and the Serrated Neoplasia Pathway
Serrated Colorectal Polyps and the Serrated Neoplasia Pathway An update on the pathology and clinical significance Mark Be(ngton Envoi Specialist Pathologists Overview 1. A framework of what is included
More informationLa genetica del carcinoma colo-rettale
La genetica del carcinoma colo-rettale Ivana Cataldo Ospedale Ca Foncello, Treviso ARC-NET Centro di Ricerca Applicata sul Cancro AOUI, Verona OUTLINE What s new in colorectal cancer? Pathological Markers
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationUpdate on Colonic Serrated (and Conventional) Adenomatous Polyps
Update on Colonic Serrated (and Conventional) Adenomatous Polyps Maui, HI 2018 Robert D. Odze, MD, FRCPC Chief, Division of GI Pathology Professor of Pathology Brigham and Women s Hospital Harvard Medical
More informationPolicy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014
Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October
More informationUpdate on the serrated pathway to colorectal carcinoma
Human Pathology (2010) xx, xxx xxx www.elsevier.com/locate/humpath Progress in pathology Update on the serrated pathway to colorectal carcinoma Dale C. Snover MD Department of Pathology, Fairview Southdale
More informationPathology of serrated colorectal lesions
Correspondence to Dr Adrian C Bateman, Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, MP002, Level E, South Block, Southampton General Hospital, Tremona Road, Southampton
More informationThe molecular genetics of colorectal cancer
1 Department of Gastroenterology, North Middlesex University Hospital, London, UK 2 Institute of Molecular Genetics, Cardiff University 3 Department of Gastroenterology, Queen s Hospital Romford, London,
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationSerrated Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO
Polyps, Part 2: Their Mechanisms and Management Ryan C. Romano, DO In the prelude to this article ( Polyps Part I: Their Confusing History) we discussed the evolution of colorectal serrated polyp classification,
More informationINTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: Received November 13, 2015; Accepted March 11, DOI: /ijmm.2016.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: 687-702 2016 Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and
More informationColorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital
Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?
More informationPathology perspective of colonic polyposis syndromes
Pathology perspective of colonic polyposis syndromes When are too many polyps too many? David Schaeffer Head and Consultant Pathologist, Department of Pathology and Laboratory Medicine, Vancouver General
More informationThe MYH Gene Status in Patients with Sporadic Colorectal Polyps
Juan, I-Cheng PhD Thesis The MYH Gene Status in Patients with Sporadic Colorectal Polyps Wielkopolskie Centrum Onkologii w Poznaniu Poznan University of Medical Sciences Poland. ZaKład Immunologii Nowotworow.
More informationColon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP
Colon cancer: practical molecular diagnostics Wade S. Samowitz, M.D. University of Utah and ARUP Disclosure Dr. Samowitz may receive royalties in the future related to the Ventana BRAF V600E antibody.
More informationM. Azzam Kayasseh,Dubai,UAE
Thanks A Lot Prof. Linda + Prof. Ernst #drkayasseh_crc_rsm #WEO_CRCSC #UEGW17 @dubaiendoscopyforum @drkayasseh.care.to.cure Twenty World Areas Age-Standardized CRC Incidence Rates by Sex GLOBOCAN 2008
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationCarol A. Burke, MD, FACG
Updated Guidelines for CRC C Screening and Surveillance Carol A. Burke MD, FACG, FASGE, FACP Cleveland Clinic, Cleveland, OH Gastroenterology t 2012;143:844 143 Gut 2010;59:666 1 Caveat for all Recommendations
More informationHereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics
From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of
More informationMolecular subtyping: how useful is it?
Molecular subtyping: how useful is it? Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics at the NCT-Partner Site Dresden CMTD Disclosure
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery prior as factor in laparoscopic colorectal surgery, 554 555 Abscess(es) CRC presenting as, 539 540 Adenocarcinoma of
More informationDouglas K. Rex, MD Indiana University Hospital Indianapolis, IN
Serrated Adenomas: What do they mean and what to do about them? Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN Colorectal Cancer Molecular Basis Pathway Frequency Genes MSI Precursor Speed
More informationOriginal Article Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma of the colorectum
Int J Clin Exp Pathol 2017;10(9):9666-9674 www.ijcep.com /ISSN:1936-2625/IJCEP0045970 Original Article Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationClinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer
Clinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer Shuji Ogino, M.D., Ph.D. Associate Professor of Pathology Harvard Medical School Brigham and Women s Hospital Dana-Farber
More informationThe Natural History of Right-Sided Lesions
The Natural History of Right-Sided Lesions Jasper L.A. Vleugels Dept of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands. None Disclosures Agenda Is there evidence that
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationColorectal Cancer Screening and Surveillance
1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal
More informationMicrosatellite instability and other molecular markers: how useful are they?
Microsatellite instability and other molecular markers: how useful are they? Pr Frédéric Bibeau, MD, PhD Head, Pathology department CHU de Caen, Normandy University, France ESMO preceptorship, Barcelona,
More informationHereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD
Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Living Beyond Cancer A-Z January 12,2019 Hereditary CRC Syndromes Objectives are to discuss the : Most common Hereditary CRC syndromes
More informationHereditary Gastric Cancer
Hereditary Gastric Cancer Dr Bastiaan de Boer Consultant Pathologist Department of Anatomical Pathology PathWest Laboratory Medicine, QE II Medical Centre Clinical Associate Professor School of Pathology
More informationWEO CRC SC Meeting. Barcelona, Spain October 23, 2015
WEO CRC SC Meeting Barcelona, Spain October 23, 2015 Identification of serrated polyposis syndrome in the context of population-based CRC screening programs Evelien Dekker Academic Medical Center Amsterdam,
More informationOvarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center
Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade
More informationResearch Article The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort
Gastroenterology Research and Practice, Article ID 374926, 1 pages http://dx.doi.org/1.1155/214/374926 Research Article The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy
More informationAnatomic Molecular Pathology: An Emerging Field
Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationKatarina Öhrling. Prognostic and Predictive Markers? Thesis for doctoral degree (Ph.D.) 2010
Thesis for doctoral degree (Ph.D.) 2010 Thesis for doctoral degree (Ph.D.) 2010 Thymidylate Synthase Expression and Mismatch Repair Protein Expression in Colorectal Cancer Thymidylate Synthase Expression
More informationMutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer
GASTROENTEROLOGY 2008;34:950 960 Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer TAKESHI NAGASAKA,* MINORU KOI,* MATTHIAS KLOOR, JOHANNES GEBERT, ALEX VILKIN,*
More informationArthur Purdy Stout Society of Surgical Pathologists Companion Meeting. Microsatellite Instability and Serrated Adenomas in Common Practice
Arthur Purdy Stout Society of Surgical Pathologists Companion Meeting Microsatellite Instability and Serrated Adenomas in Common Practice United States and Canadian Academy of Pathology Annual Meeting
More informationManagement of higher risk of colorectal cancer. Huw Thomas
Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)
More informationSupplementary Table 1. PIK3CA mutation in colorectal cancer
Liao X et al. PIK3CA Mutation in Colorectal Cancer. Page 1 Supplementary Table 1. PIK3CA mutation in colorectal cancer Exon Domain Nucleotide change* Amino acid change* cases 9 Helical c.1621t>a p.e541t
More informationNIH Public Access Author Manuscript Gastroenterology. Author manuscript; available in PMC 2009 June 1.
NIH Public Access Author Manuscript Published in final edited form as: Gastroenterology. 2008 June ; 134(7): 1950 1960.e1. doi:10.1053/j.gastro.2008.02.094. Mutations in both KRAS and BRAF may contribute
More informationFAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry
FAMILIAL COLORECTAL CANCER Lyn Schofield Manager Familial Cancer Registry Cancer in WA 2004 4000 3500 ASPR, rate per 100,000 3000 2500 2000 1500 1000 Male incidence Female incidence Male mortality Female
More informationYes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationGenetic Modifiers of Chemotherapy for Colorectal Cancer
Genetic Modifiers of Chemotherapy for Colorectal Cancer September 27, 2011 John M. Carethers, M.D. Professor of Internal Medicine University of Michigan 1,233,700 cases/year Worldwide ~146,000 cases/year
More informationThe silence of the genes: clinical applications of (colorectal) cancer epigenetics
The silence of the genes: clinical applications of (colorectal) cancer epigenetics Manon van Engeland, PhD Dept. of Pathology GROW - School for Oncology & Developmental Biology Maastricht University Medical
More informationMarcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari
Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari Milo Frattini XII Congresso AIFEG Villa Cagnola - Gazzada Schianno (VA) 16/17.10.2014 APC β-catenina APC Met (p16) Models of
More informationcolorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018
colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast
More informationThe Clinical Significance of Serrated Polyps
CLINICAL AND SYSTEMATIC S nature publishing group 229 CME The Clinical Significance of Serrated Polyps Christopher S. Huang, MD 1, Fr anc is A. Far raye, M D, M S c 1, Sh i Yang, M D 2 and Michael J. O
More informationDetermination Differentiation. determinated precursor specialized cell
Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:
More informationColorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi
Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change
More informationSessile serrated polyps: Cancer risk and appropriate surveillance
REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will understand the role of the recently recognized serrated neoplasia pathway in the development of colorectal cancer ROHIT MAKKAR, MD St. Michael s Hospital,
More informationCOLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014
COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS
More informationThe Importance of Complete Colonoscopy and Exploration of the Cecal Region
The Importance of Complete Colonoscopy and Exploration of the Cecal Region Kuangi Fu, Takahiro Fujii, Takahisa Matsuda, and Yutaka Saito 2 2.1 The Importance of a Complete Colonoscopy Ever since case-control
More informationColorectal Carcinoma Reporting in 2009
Colorectal Carcinoma Reporting in 2009 Overview Colorectal carcinoma- new and confusing AJCC TNM issues Wendy L. Frankel, M.D. Vice-Chair and Director of AP Department of Pathology The Ohio State University
More informationDNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression
Ittai Bernardo Muller Student no. 3257886 DNA methylation: An important mechanism in colorectal carcinogenesis and pretumor progression June 2011 Biomedical Sciences University Utrecht Thesis This thesis
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationContent. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome
of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines
More informationColon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow
Colon Cancer Screening & Surveillance Amit Patel, MD PGY-4 GI Fellow Epidemiology CRC incidence and mortality rates vary markedly around the world. Globally, CRC is the third most commonly diagnosed cancer
More informationMolecular Diagnosis for Colorectal Cancer Patients
Molecular Diagnosis for Colorectal Cancer Patients Antonia R. Sepulveda MD, PhD, FCAP October, 20, 2010 www.cap.org Welcome to the PHC Webinar Series This talk on The Molecular Diagnosis for Colorectal
More informationDisclaimer: I belong to the speakers bureau of the American Serrated Society, often referred to as the ASS
An Exposé on Serrated Lesions of the Colorectum How do you know it is a hyperplastic polyp and not something else? How do you know it is something else and not a hyperplastic polyp? Disclaimer: I belong
More informationSessile Serrated Polyps: An Important Route to Colorectal Cancer
Focused Review 1585 Sessile Serrated Polyps: An Important Route to Colorectal Cancer Matthew F. Kalady, MD Abstract The serrated neoplastic pathway accounts for approximately 30% of colorectal cancers.
More informationColon Cancer Update Christie J. Hilton, DO
POMA Winter Conference Christie Hilton DO Medical Oncology January 2018 None Colon Cancer Numbers Screening (brief update) Practice changing updates in colon cancer MSI Testing Immunotherapy in Colon Cancer
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationMolecular pathogenesis of serrated carcinoma of the colon
Molecular pathogenesis of serrated carcinoma of the colon Winnie Collet Fernando Master of Molecular Biology Bachelor of Technology in Industrial Biotechnology Griffith School of Biomolecular and Physical
More informationHyperplastic polyps in hereditary nonpolyposis colorectal cancer
4 Hyperplastic polyps in hereditary nonpolyposis colorectal cancer F E M Rijcken 1, T van der Sluis 2, H Hollema 2, J H Kleibeuker 1 Department of Gastroenterology 1 and Pathology 2, University Medical
More informationGENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome
GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual
More informationUniversal Screening for Lynch Syndrome
Universal Screening for Lynch Syndrome St. Vincent/Ameripath protocol proposal Lynch syndrome (HNPCC) 1/35 individuals with colorectal cancer has Lynch syndrome Over half individuals are >50 at time of
More informationReview Article Serrated Polyposis: An Enigmatic Model of Colorectal Cancer Predisposition
SAGE-Hindawi Access to Research Pathology Research International Volume 2011, Article ID 157073, 13 pages doi:10.4061/2011/157073 Review Article Serrated Polyposis: An Enigmatic Model of Colorectal Cancer
More informationNoninvasive Molecular Detection of Colorectal Neoplasia
Disclosures Noninvasive Molecular Detection of Colorectal Next Generation Approaches David Ahlquist August 7, 29 Relationship with Exact Sciences Mayo Clinic is equity investor Potential for future royalties
More informationHereditary Cancer Syndromes
Hereditary Cancer Syndromes Nicoleta Voian, MD, MPH Director Clinical Genetics Service Roswell Park Cancer Institute Nicoleta.Voian@Roswellpark.org February 28, 2017 Common Genetics Terms Gene: A hereditary
More informationMolecular biology of colorectal cancer
Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes
More informationMolecular markers in colorectal cancer. Wolfram Jochum
Molecular markers in colorectal cancer Wolfram Jochum Biomarkers in cancer Patient characteristics Tumor tissue Normal cells Serum Body fluids Predisposition Diagnostic marker Specific diagnosis Prognostic
More informationTitle: Serrated polyposis syndrome associated with long-standing inflammatory bowel disease
Title: Serrated polyposis syndrome associated with long-standing inflammatory bowel disease Authors: Jesús Castro, Miriam Cuatrecasas, Francesc Balaguer, Elena Ricart, María Pellisé DOI: 10.17235/reed.2017.5068/2017
More information6 semanas de embarazo. Tubulovillous adenoma with dysplasia icd 10. Inicio / Embarazo / 6 semanas de embarazo
Inicio / Embarazo / 6 semanas de embarazo 6 semanas de embarazo Tubulovillous adenoma with dysplasia icd 10 Free, official coding info for 2018 ICD-10-CM D13.2 - includes detailed rules, notes, synonyms,
More informationSerrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice?
Virchows Arch (2007) 450:613 618 DOI 10.1007/s00428-007-0413-8 ORIGINAL ARTICLE Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice?
More informationMr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer
Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth
More information